benefits of microdosing glp 1 in menopause THE PCCA BLOG The Benefits of Micro-Dosing GLP-1

The real question is whether this space will mature into a legitimate, responsible arm of obesity medicine or be dismissed as a chaotic market of pill mills

2023 Dec 21;16(1):34

Clinical data from GLP-1 trials show mean reductions in systolic blood pressure ranging from 2 to 5 mmHg, though individual variation is substantial

Positive results would not prove that resM is equivalent to prescription medications

In some embodiments, the otic formulation or composition comprises about 0.6% by weight of the carbomer

Importantly, as shown in the first row, LASSS supplementation effectively prevented an increase in the nitration level of ECM-HGF, whereas GSSSG did not demonstrate efficacy, inconsistent with its potent potential shown in in vitro experiments described earlier (see Figure 1b)